MiMedx Group (NASDAQ: MDXG) reported Q3 EPS of $0.15, $0.09 better than the analyst estimate of $0.06. Revenue for the quarter came in at $113.7 million versus the consensus estimate of $94.73 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.